Researchers have launched a clinical trial to test an immunotherapy drug in patients who have both cancer and an autoimmune disease, such as rheumatoid arthritis, lupus, or multiple sclerosis. Immunotherapy drugs enhance the ability of the immune system to detect and kill tumor cells. In recent years, these therapies have benefited a growing number of patients, including some patients with advanced cancers.

READ THE STUDY